Rapid COVID-19 antigen test
Available from stock
BfArM Test ID: AT064 / 20
Highest test quality:
Sensitivity: 92.0% (positive test)
Specificity: 99.26% (negative testing)
The antigen test reliably and quickly triggers people with suspected SARS-CoV-2.
The results are available within 15 minutes and thus enable people to be identified quickly.
Easy handling without an additional analysis system
Sample material: nasopharynx
Test intended for professional use
Packing unit: 25 pieces per pack
The SARS-CoV-2 antigen test offers a fast and reliable answer for both symptomatic and asymptomatic patients with regard to a SARS-CoV-2 infection. For example, a precise screening of people with known contact with SARS-CoV-2 infected people can be carried out and the infection status can be determined. The SARS-CoV-2 Antigen Test Kit contains all the necessary materials and can be used by medical professionals regardless of location.
On January 26, 2021, the PEI's report on an official test stated that the Federal Institute for Drugs and Medical Devices (BfArM) was authorized to carry out that the Lepu SARS-CoV-2 antigen rapid test kit met all the minimum requirements for antigen tests that carried out by PEI in consultation with the Robert Koch Institute (RKI).
The antigen rapid test kit contains the following products:
Rapid tests (25 pieces / pack)
Instructions for use / package insert
Storage condition: 4 - 30 ° C
Shelf life: 12 months
Your result in just 5 steps and 15 minutes
Step 1: use the swab to collect samples.
Step 2: peel off the glue.
Step 3: Insert the swab from well B into well A.
Step 4: 6 Drop the buffer solution into well A. Rotate the shaft two rounds in each direction.
Step 5: Fold the left side over and wait 15 minutes.
The SARS-CoV-2 antigen test is carried out near the patient by medical specialists. This is particularly advantageous when decisions have to be made promptly or laboratory tests are difficult to access. The test helps to identify infected people quickly, enables better patient management and more effective use of health care resources. The results are intended to facilitate the early diagnosis of SARS-CoV-2 infection in patients with clinical symptoms of SARS-CoV-2 and to help with the initial examination of patients. In addition, it serves as a valuable supplement in diagnostics for the initial screening of people who have direct contact with SARS-CoV-2 infected people or those who have been exposed to a high-risk environment. This can prevent the virus from spreading and contain the pandemic.
You confirm that you are placing the order for commercial / medical purposes and that you are handing over the products to the appropriate qualified personnel.
When handling the pack reagents, wear personal protective equipment such as an FFP2 mask, eye protection or shield, gloves and a lab coat. Wash your hands thoroughly after performing the tests.
In the event of a spill, ensure thorough cleaning with a suitable virucidal disinfectant.
When handling specimens, follow safety precautions for infectious substances.
Take proven precautions to protect against microbiological hazards throughout the testing process.